Ustekinumab does not increase risk of new or recurrent cancer in inflammatory bowel disease patients with prior malignancy
暂无分享,去创建一个
N. Narula | R. Charles | K. Tandon | Fernando J. Castro | A. Riaz | Badar Hasan | Adalberto Gonzalez | Asad ur Rahman | R. Miret | Sikandar Khan | Asad Ur Rahman | F. Castro